![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Liver Diseases |
Free Subscription
3 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Liver Diseases is free of charge.
Intravascular Ultrasound Guidance for Transjugular Intrahepatic Portosystemic
Shunt Procedures: A Review.
AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27626.
PubMed
Abstract available
Editorial Comment: Hepatocellular Carcinoma Screening Guidelines Are Needed in
Children With Predisposing Conditions.
AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27975.
PubMed
Beyond the AJR: Shorter Ultrasound Screening Intervals for Hepatocellular
Carcinoma Improve Patient Outcomes.
AJR Am J Roentgenol. 2022;218:761.
PubMed
Hydrochloride Berberine ameliorates alcohol-induced liver injury by regulating
inflammation and lipid metabolism.
Biochem Biophys Res Commun. 2022;610:49-55.
PubMed
Abstract available
Methylation of the HCBP6 promoter is associated with primary biliary cholangitis
pathogenesis.
Biochem Biophys Res Commun. 2022;610:176-181.
PubMed
Abstract available
Characteristics of acute kidney injury and its impact on outcome in patients with
acute-on-chronic liver failure.
BMC Gastroenterol. 2022;22:231.
PubMed
Abstract available
Immunohistochemical identification and assessment of the location of leptin,
visfatin and chemerin in the liver of men with different body mass index.
BMC Gastroenterol. 2022;22:233.
PubMed
Abstract available
Distribution of FIB-4 index in the general population: analysis of 75,666
residents who underwent health checkups.
BMC Gastroenterol. 2022;22:241.
PubMed
Abstract available
Non-tuberculosis extensive abdominal lymph node calcification leading to portal
hypertension with esophageal and gastric variceal bleeding: a rare case report.
BMC Gastroenterol. 2022;22:245.
PubMed
Abstract available
Pathophysiological mechanisms of ALPPS: experimental model.
Br J Surg. 2022;109:510-519.
PubMed
Abstract available
Preoperative morphometric measurements of liver vasculature to predict
postoperative liver failure: bicentric study.
Br J Surg. 2022;109:554-555.
PubMed
Cost-effectiveness of liver transplantation versus last-resort systemic therapy
for colorectal liver metastases.
Br J Surg. 2022;109:483-485.
PubMed
Wrapping of the hepatic artery using the round ligament during laparoscopic
pancreatoduodenectomy to prevent postpancreatectomy haemorrhage.
Br J Surg. 2022 May 17. pii: 6586618. doi: 10.1093.
PubMed
Erratum to: Comment on: Laparoscopic versus open resection of intrahepatic
cholangiocarcinoma: nationwide analysis.
Br J Surg. 2022;109:551.
PubMed
Histologic type predicts disparate outcomes in pediatric hepatocellular
neoplasms: A Pediatric Surgical Oncology Research Collaborative study.
Cancer. 2022 May 13. doi: 10.1002/cncr.34256.
PubMed
Abstract available
Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled
Plasticity at the Micrometastatic Stage.
Cancer Res. 2022;82:1953-1968.
PubMed
Abstract available
RNA Helicase DHX37 Facilitates Liver Cancer Progression by Cooperating with PLRG1
to Drive Superenhancer-Mediated Transcription of Cyclin D1.
Cancer Res. 2022;82:1937-1952.
PubMed
Abstract available
Immune Surveillance by Myeloid-Derived Suppressor Cells in Liver Diseases.
Dig Dis. 2022;40:301-312.
PubMed
Abstract available
Comparison between CT volumetry and extracellular volume fraction using liver
dynamic CT for the predictive ability of liver fibrosis in patients with
hepatocellular carcinoma.
Eur Radiol. 2022 May 20. pii: 10.1007/s00330-022-08852.
PubMed
Abstract available
Performance of adding hepatobiliary phase image in magnetic resonance imaging for
detection of hepatocellular carcinoma: a meta-analysis.
Eur Radiol. 2022 May 17. pii: 10.1007/s00330-022-08826.
PubMed
Abstract available
Comparison of a preoperative MR-based recurrence risk score versus the
postoperative score and four clinical staging systems in hepatocellular
carcinoma: a retrospective cohort study.
Eur Radiol. 2022 May 13. pii: 10.1007/s00330-022-08811.
PubMed
Abstract available
Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an
Undernutrition Perspective.
Gastroenterology. 2022;162:1858-1875.
PubMed
Abstract available
Clinical Care Pathway for the Risk Stratification and Management of Patients With
Non-alcoholic Fatty Liver Disease.
Gastroenterology. 2022;162:2131-2132.
PubMed
Proton Pump Inhibitors for Patients with Cirrhosis: Good Medicine or Poison?
Gastroenterology. 2022 May 17. pii: S0016-5085(22)00514.
PubMed
Intrahepatic bile duct foreign body with cholangitis after pylorus preserving
pancreatoduodenectomy: Is it a fish bone?
Gastroenterology. 2022 May 14. pii: S0016-5085(22)00507.
PubMed
NOTCH-YAP1/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic
cholangiocarcinoma.
Gastroenterology. 2022 May 9. pii: S0016-5085(22)00477.
PubMed
Abstract available
Hepatic p63 regulates glucose metabolism by repressing SIRT1.
Gut. 2022 May 17. pii: gutjnl-2021-326620. doi: 10.1136/gutjnl-2021-326620.
PubMed
Abstract available
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma
with therapeutic implications.
Gut. 2022 May 18. pii: gutjnl-2021-326514. doi: 10.1136/gutjnl-2021-326514.
PubMed
Abstract available
Lipocalin-2 Activates Hepatic stellate cells and Promotes Non-alcoholic
Steatohepatitis in High-Fat Diet-Fed ob/ob mice.
Hepatology. 2022 May 13. doi: 10.1002/hep.32569.
PubMed
Abstract available
Impact of Bacterial Infections and SBP Prophylaxis on Phage-Bacterial Dynamics in
Cirrhosis.
Hepatology. 2022 May 13. doi: 10.1002/hep.32571.
PubMed
Abstract available
Multiomics identifies the link between intratumor steatosis and the exhausted
tumor immune microenvironment in hepatocellular carcinoma.
Hepatology. 2022 May 14. doi: 10.1002/hep.32573.
PubMed
Abstract available
Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis:
associations in a large community cohort.
Hepatology. 2022 May 14. doi: 10.1002/hep.32575.
PubMed
Abstract available
Hepatology highlights.
Hepatology. 2022;75:1363-1364.
PubMed
Hepatocellular Cystathionine gamma lyase/Hydrogen sulfide Attenuates
Non-Alcoholic Fatty Liver Disease by Activating Farnesoid X Receptor.
Hepatology. 2022 May 19. doi: 10.1002/hep.32577.
PubMed
Abstract available
Extracellular vesicles derived from mesenchymal stem/stromal cells: The
regenerative impact in liver diseases.
Hepatology. 2022;75:1590-1603.
PubMed
Abstract available
High-quality diet, physical activity, and college education are associated with
low risk of NAFLD among the US population.
Hepatology. 2022;75:1491-1506.
PubMed
Abstract available
Switch-associated protein 70 protects against nonalcoholic fatty liver disease
through suppression of TAK1.
Hepatology. 2022;75:1507-1522.
PubMed
Abstract available
The pathophysiology of Wilson's disease visualized: A human (64) Cu PET study.
Hepatology. 2022;75:1461-1470.
PubMed
Abstract available
Frailty, Mortality, and Healthcare Utilization after Liver Transplantation: From
the Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study.
Hepatology. 2021 Dec 4. doi: 10.1002/hep.32268.
PubMed
Abstract available
Effect of increased alcohol consumption during COVID-19 pandemic on
alcohol-associated liver disease: A modeling study.
Hepatology. 2022;75:1480-1490.
PubMed
Abstract available
Letter to the editor: Chronic liver disease among adolescents and young adults:
Alcohol use disorder identification.
Hepatology. 2022;75:1662-1663.
PubMed
Liver transplantation following SARS-CoV-2 vaccination-induced liver failure.
Hepatology. 2022 Feb 17. doi: 10.1002/hep.32409.
PubMed
Cholestatic Liver Diseases of Genetic Etiology: Advances and Controversies.
Hepatology. 2022 Mar 1. doi: 10.1002/hep.32437.
PubMed
Abstract available
Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis
in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Indian J Gastroenterol. 2022;41:119-126.
PubMed
Abstract available
Dynamic microbiome and metabolome analyses reveal the interaction between gut
microbiota and anti-PD-1 based immunotherapy in hepatocellular carcinoma.
Int J Cancer. 2022 May 17. doi: 10.1002/ijc.34118.
PubMed
Abstract available
Are H1-Antihistamines Associated With a Lower Risk of Hepatocellular Carcinoma?
J Clin Oncol. 2022 May 12:JCO2200179. doi: 10.1200/JCO.22.00179.
PubMed
Can Posttransarterial Chemoembolization Volumetric Oil Deposition on Computed
Tomography Predict Treatment Response on Magnetic Resonance Imaging in
Leiomyosarcoma Metastases to the Liver?
J Comput Assist Tomogr. 2022;46:327-332.
PubMed
Abstract available
Personalized treatment for hepatocellular carcinoma: Current status and Future
perspectives.
J Gastroenterol Hepatol. 2022 May 15. doi: 10.1111/jgh.15889.
PubMed
Abstract available
Endoscopic ultrasound-guided portal pressure gradient with liver biopsy: 6 years
of endo-hepatology in practice.
J Gastroenterol Hepatol. 2022 May 5. doi: 10.1111/jgh.15875.
PubMed
Abstract available
Corrigendum to 'Population-level estimates of hepatitis C reinfection post
scale-up of direct-acting antivirals among people who inject drugs' [J Hepatol 76
(2022) 549-557].
J Hepatol. 2022 May 9. pii: S0168-8278(22)00248.
PubMed
Hepatoblastomas with carcinoma features represent a biological spectrum of
aggressive neoplasms in children and young adults.
J Hepatol. 2022 May 13. pii: S0168-8278(22)00275.
PubMed
Abstract available
Corrigendum to 'High prevalence of hepatitis C infection among
multidrug-resistant tuberculosis patients' [J Hepatol 72 (2020) 1028-1029].
J Hepatol. 2022 May 14. pii: S0168-8278(22)00247.
PubMed
Exacerbation of Familial Intrahepatic Cholestasis in Conjunction with COVID-19
Vaccination.
J Hepatol. 2022 May 16. pii: S0168-8278(22)00313.
PubMed
Breakthroughs in hepatology.
J Hepatol. 2022;76:1247-1248.
PubMed
Haemostatic alterations and management of haemostasis in patients with cirrhosis.
J Hepatol. 2022;76:1291-1305.
PubMed
Abstract available
Long-term albumin treatment in patients with cirrhosis and ascites.
J Hepatol. 2022;76:1306-1317.
PubMed
Abstract available
Artificial intelligence for the prevention and clinical management of
hepatocellular carcinoma.
J Hepatol. 2022;76:1348-1361.
PubMed
Abstract available
Impact of non-invasive biomarkers on hepatology practice: Past, present and
future.
J Hepatol. 2022;76:1362-1378.
PubMed
Abstract available
Prohaptoglobin inhibits the transforming growth factor-beta-induced
epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation
and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.
PLoS One. 2022;17:e0266409.
PubMed
Abstract available
Features of fibrosis regression abound in "non-cirrhotic" patients with resected
hepatocellular carcinoma.
PLoS One. 2022;17:e0267474.
PubMed
Abstract available
The Immune Response: A New Frontier in Interventional Oncology.
Radiology. 2022;303:229-230.
PubMed
Contrast-enhanced US of the Liver and Kidney: A Problem-solving Modality.
Radiology. 2022;303:11-25.
PubMed
Abstract available
Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?
Radiology. 2022;303:226-228.
PubMed
Reduced-Dose Deep Learning Reconstruction for Abdominal CT of Liver Metastases.
Radiology. 2022 Jan 11:211838. doi: 10.1148/radiol.211838.
PubMed
Abstract available
Activated AXL Protects Against Hepatic Ischemia-reperfusion Injury by
Upregulating SOCS-1 Expression.
Transplantation. 2022 May 11. pii: 00007890-990000000-00043.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by